Dogwood Therapeutics DWTX Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Dogwood Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The official record: Dogwood Therapeutics’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dogwood Therapeutics's comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dogwood Therapeutics's comprehensive income (loss), net of tax, attributable to parent?
- Dogwood Therapeutics (DWTX) reported comprehensive income (loss), net of tax, attributable to parent of -$6.12M in Q1 2026.
- How has Dogwood Therapeutics's comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Dogwood Therapeutics's comprehensive income (loss), net of tax, attributable to parent increased by 43.7% year-over-year, from -$10.86M to -$6.12M.
- What is the long-term trend for Dogwood Therapeutics's comprehensive income (loss), net of tax, attributable to parent?
- Over 2 years (2023 to 2025), Dogwood Therapeutics's comprehensive income (loss), net of tax, attributable to parent has grown at a 141.9% compound annual growth rate (CAGR), from -$5.3M to -$30.98M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- This metric captures the change in equity of a business enterprise during a period from transactions and other events from non-owner sources, including items not reflected in net income. It encompasses unrealized gains or losses, such as those from foreign currency translation adjustments or changes in the fair value of certain financial instruments. It provides a broader view of the company's financial performance beyond traditional net income.